Back
Assembly Biosciences Vs. Protagonist Therapeutics Industry Stock Comparison
Sell
26
ASMB
Assembly Biosciences
Last Price:
16.67
Seasonality Move:
1.78%
Sell
44
PTGX
Protagonist Therapeutics
Last Price:
48.04
Seasonality Move:
18.58%
Sell
26
Assembly Biosciences (ASMB)
is a Sell
Is Assembly Biosciences a Buy, Sell or Hold?
- The current Assembly Biosciences [ASMB] share price is $16.56. The Score for ASMB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- ASMB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $45.90. The Score for PTGX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASMB Stock Price Chart
What is Assembly Biosciences's stock price today?
-
The Assembly Biosciences share price today is $16.56
The current trend is moderately bearish and ASMB is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $45.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
ASMB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 48.51 | Sell |
| Chaikin Money Flow: | -21789 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.31 - 17.59) | Buy |
| Bollinger Bands (100): | (14.01 - 17.01) | Buy |
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 48.74 | Sell |
| Chaikin Money Flow: | 154951 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.55 - 47.39) | Sell |
| Bollinger Bands (100): | (35.98 - 45.9) | Buy |
ASMB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.92 | Sell |
| 20-day SMA: | 16.88 | Sell |
| 50-day SMA: | 16.62 | Sell |
| 200-day SMA: | 14.34 | Buy |
| 8-day EMA: | 16.79 | Sell |
| 20-day EMA: | 16.74 | Sell |
| 50-day EMA: | 16.34 | Buy |
| 200-day EMA: | 14.69 | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.09 | Sell |
| 20-day SMA: | 46.37 | Sell |
| 50-day SMA: | 45.14 | Buy |
| 200-day SMA: | 34.63 | Buy |
| 8-day EMA: | 46.69 | Sell |
| 20-day EMA: | 46.38 | Sell |
| 50-day EMA: | 44.64 | Buy |
| 200-day EMA: | 35.99 | Buy |
Assembly Biosciences Earnings Growth & ASMB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.81 per share, and an increase next year of $0.78 per share.
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.98 per share, and a decrease next year of $3.62 per share.
Assembly Biosciences Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protagonist Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||